Psychedelic Medicines Working Group Members

Director of the Department of Health and Human Services or his or her designee

Attorney General or his or her designee

Director of the Department of Veterans Services or his or her designee

President of the State Board of Pharmacy or his or her designee

One member appointed by the Majority Leader of the Senate

One member appointed by the Minority Leader of the Senate

One member appointed by the Speaker of the Assembly

One member appointed by the Minority Leader of the Assembly

One member who has received an honorable discharge from the Armed Forces of the United States and who has experience with the use of entheogens to address post-traumatic stress disorder

One member who is a representative of an organization that advocates for and provides education to the public regarding the therapeutic use of entheogens

One member who is a representative of a law enforcement agency in this State

One member who is a psychiatrist, or a psychologist with clinical experience, and who: (I) Is licensed to practice in this State; and (II) Has experience treating patients who have an alcohol or other substance use disorder

One member who has experience treating post-traumatic stress disorder in a clinical setting

One member who has experience researching the therapeutic use of entheogens pursuant to a license issued by the Drug Enforcement Administration of the United States Department of Justice

One member who is a representative of a tribal government, as defined in NRS 239C.105, in this State